BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, February 5, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 26, 2019

View Archived Issues

De novo loss-of-function mutations in FOXJ1 cause a motile ciliopathy characterized by hydrocephalus

Read More

AQP9 expression correlates with clear cell RCC progression and may have prognostic value

Read More

Analysis of genetic risk locus associated with abdominal aortic calcification identifies HDAC9

Read More

Malaria discovery may lead to better HIV and lupus treatments

Read More

Binging brains give themselves away

Read More

In cancer cells, beware the vicious circle

Read More

HLX-07 displays antitumor activity in patients with advanced solid tumors

Read More

New G12C mutant GTPase KRAS inhibitors identified at AstraZeneca

Read More

APRINOIA Therapeutics describes compounds targeting microtubule-associated protein tau

Read More

Shanghai Institute of Materia Medica patents farnesoid X receptor agonists

Read More

UCB discovers synaptic vesicle glycoprotein 2A/2C ligands

Read More

Aziende Chimiche Riunite Angelini Francesco presents GSK-3beta inhibitors

Read More

Antifilarial therapy against onchocerciasis presented

Read More

TFF Pharmaceuticals initiates phase I study of voriconazole inhalation powder

Read More

Agenus studies anti-CD137 antibody AGEN-2373 in phase I for advanced cancer

Read More

ORCA Therapeutics initiates first-in-human study of ORCA-010 in prostate cancer

Read More

Clinical activity seen with sitravatinib and nivolumab in refractory urothelial carcinoma

Read More

Adamis Pharmaceuticals receives a complete response letter regarding Zimhi

Read More

CymaBay stops clinical development of seladelpar

Read More

Takeda Vaccines presents data on TAK-426 for Zika virus

Read More

Phase III ADVOCATE trial of avacopan in ANCA vasculitis meets primary endpoints

Read More

EpicentRx reports phase I data on RRx-001 in newly diagnosed glioblastoma

Read More

ACADIA reports phase II topline results on pimavanserin for negative symptoms of schizophrenia

Read More

Poxel reports topline data from TIMES 3 open-label extension of imeglimin in type 2 diabetes

Read More

Enrollment underway in ImmunoGen's phase I/II study of IMGN-632 in AML

Read More

FDA grants accelerated approval to Oxbryta for sickle cell disease

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Feb. 4, 2025.
  • Today's news in brief

    Briefs
    BioWorld MedTech briefs for Jan. 30, 2026.
  • Art concept for medical research

    MicroRNAs in circulating extracellular vesicles as IPF biomarkers

    BioWorld Science
    MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
  • Brain illustration

    MJFF grant supports Bexorg’s translational biomarker work

    BioWorld Science
    Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
  • Brain and DNA

    REST emerges as biomarker in ALS, knockdown improves ALS symptoms

    BioWorld Science
    About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing